EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Leveraging the global genomic epidemiology of carbapenemase-producing Klebsiella pneumoniae to inform infection prevention in Tunisian hospitals

Basma Menif iD, Jay N Worley iD, Noura Ben Mansour, Faouzia Mahjoubi, Adnene Hammami, Lynn Bry iD

Antimicrobial Agents and Chemotherapy · 03.06.2026 · 70 (6)

DOI: 10.1128/aac.00142-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 03.06.2026. Verfasst von Basma Menif und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microbiology, Habib Bourguiba University Hospital, Sfax University, Sfax, Tunisia. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, beta-Lactamases, Bacterial Proteins, Klebsiella Infections. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Health for the Research Laboratory « Micro-organismes et Pathologies Humaines » of Habib Bourguiba University Hospital, National Center for Biotechnology Information of the National Library of Medicine (NLM), NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbapenemase-producing Klebsiella pneumoniae (CPK) is a major threat in North Africa, yet long-term genomic surveillance efforts remain scarce. To address this, we analyzed 1,013 CPK clinical isolates collected at Habib Bourguiba Hospital (Sfax, Tunisia) from 2009 to 2022. Given limited genomic resources, clinical microbiologic and pulse-field gel electrophoresis (PFGE) profiles identified representative isolates for genomic analyses to resolve transmission dynamics and plasmid dissemination over time. Hospital-acquired CPK increased >10-fold, from 0.95 to 9.59 per 10,000 patient-days. OXA-48-like enzymes predominated, followed by NDMs and dual producers. Genomic analyses identified 23 sequence types, with ST101, ST147, and ST383 accounting for 70% of isolates. ST383 strains carrying bla OXA-204 on IncC plasmids occurred first, followed by ST101 with bla OXA-48 on IncL replicons and ST147 with bla NDM-1 on IncFIB/IncFII multi-replicons. Since 2019, epidemic ST383 co-harboring bla OXA-48 on IncL plasmids and bla NDM-5 with rmpA/iuc on hybrid IncFIB/IncHI1B plasmids became dominant. Comparison with 80,252 global genomes in NCBI Pathogen Detection showed that 82% of study isolates clustered with Mediterranean/global lineages, demonstrating frequent international dissemination. Findings reveal both local and international reservoirs driving CPK introductions, informing targeted infection-control strategies in regional hospitals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaebeta-LactamasesBacterial ProteinsKlebsiella InfectionsTunisiaHumansPlasmidsAnti-Bacterial AgentsCross InfectionMicrobial Sensitivity TestsHospitalsMolecular EpidemiologyMultilocus Sequence Typing

Stichwörter der Autor:innen

Tunisiacarbapenemase-producing K. pneumoniaegenomic epidemiology

Substanzen

beta-LactamasesBacterial ProteinscarbapenemaseAnti-Bacterial Agents

Autor:innen und Institutionen

  • Laboratory of Microbiology, Habib Bourguiba University Hospital, Sfax University, Sfax, Tunisia.
  • School of Medicine of Sfax, Sfax University, Sfax, Tunisia.
  • Massachusetts Host-Microbiome Center, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland, USA.
  • Clinical Microbiology Laboratory, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Basma Menif, Jay N Worley, Lynn Bry

Förderung

  • The Ministry of Health for the Research Laboratory « Micro-organismes et Pathologies Humaines » of Habib Bourguiba University Hospital
  • National Center for Biotechnology Information of the National Library of Medicine (NLM)
  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Menif, B., Worley, J. N., Ben Mansour, N., Mahjoubi, F., Hammami, A., & Bry, L. (2026). Leveraging the global genomic epidemiology of carbapenemase-producing Klebsiella pneumoniae to inform infection prevention in Tunisian hospitals. Antimicrobial Agents and Chemotherapy, 70(6). https://doi.org/10.1128/aac.00142-26

Vancouver

Menif B, Worley JN, Ben Mansour N, Mahjoubi F, Hammami A, Bry L. Leveraging the global genomic epidemiology of carbapenemase-producing Klebsiella pneumoniae to inform infection prevention in Tunisian hospitals. Antimicrobial Agents and Chemotherapy. 2026;70(6). doi:10.1128/aac.00142-26

BibTeX
@article{Menif2026,
  author = {Menif, Basma and Worley, Jay N and Ben Mansour, Noura and Mahjoubi, Faouzia and Hammami, Adnene and Bry, Lynn},
  title = {Leveraging the global genomic epidemiology of carbapenemase-producing Klebsiella pneumoniae to inform infection prevention in Tunisian hospitals},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  volume = {70},
  number = {6},
  doi = {10.1128/aac.00142-26}
}
Kostenlos starten →